rfhg_193743.1

Basic information about the TSS

---

TSS ID: rfhg_193743.1 Species: human Chr: chr17		Start: 41913896 End: 41913898 Strand: -
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D2932032,EH38E1863023)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AB384384:21 GeneID: 47 HGNC/MGI_ID: HGNC:115 UniProt_ID: Nearer transcript ids and distances:

Gene_name: ACLY Gene_symbol: ACLY Gene_synonyms: ACL ATPCL CLATP Gene_source: HGNC:115

TATA-Box annotation

---

Distance to TSS:	5054
Nearest PromoterID:	NM_001096
Entrez ID:	47
Nearest Unigene:	Hs.387567
Nearest Refseq:	NM_001096
Nearest Ensembl:	ENSG00000131473
Gene Name:	ACLY
Gene Alias:	ACL|ATPCL|CLATP
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ACLY p2@ACLY p3@ACLY p4@ACLY
Sample		p1@ACLY	p2@ACLY	p3@ACLY	p4@ACLY
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	37.60	28.44	2.34	2.53
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	47.14	28.73	1.62	2.02
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	40.70	32.41	2.51	3.28
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	38.46	23.70	1.66	3.33
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	40.72	25.20	2.02	2.02
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	38.37	29.07	2.52	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	44.67	35.08	2.83	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	34.15	28.82	1.70	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	37.83	27.36	1.92	2.56
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	26.66	23.19	2.90	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.02	16.57	1.62	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	20.33	23.58	1.22	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.67	18.70	0.81	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.71	18.94	0.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	7.90	17.56	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	5.78	11.82	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	4.15	12.23	1.09	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.91	12.65	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	14.40	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.08	17.15	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	9.22	14.97	0.94	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.60	17.43	0.86	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.60	14.48	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.22	14.80	0.97	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.32	17.80	1.29	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.86	14.56	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	11.54	13.19	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.73	19.10	1.65	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	13.08	14.70	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.75	19.91	0.54	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	12.98	12.14	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.18	16.41	0.98	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.44	14.14	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.22	15.34	0.49	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.65	14.21	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	15.71	15.33	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.88	15.74	0.61	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.88	14.51	0.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.61	19.18	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.88	18.00	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.53	13.41	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.37	17.42	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.76	14.97	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.81	19.41	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	13.65	17.27	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.68	20.47	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.28	14.87	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	16.99	19.67	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.78	18.43	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.18	21.23	0.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	13.32	16.19	2.66	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	17.35	20.90	1.11	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.84	19.52	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.89	19.22	2.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	4.19	15.10	5.87	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	11.02	19.29	2.30	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	16.85	29.17	3.89	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.95	22.80	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.52	25.15	1.26	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	23.97	19.04	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	22.99	19.07	3.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	5.57	14.33	4.78	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.87	16.65	1.02	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	20.79	19.50	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	23.43	23.07	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	23.69	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	64.35	22.43	3.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	62.48	33.72	4.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	52.54	39.87	3.28	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	52.66	37.42	6.95	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	73.00	30.62	3.71	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	69.10	33.94	3.36	0.61
Adipocyte - breast, donor1	11376-118A8	38.33	23.76	0.95	0.16
Adipocyte - breast, donor2	11327-117E4	308.18	17.17	23.90	0.32
Adipocyte - omental, donor1	11473-119C6	74.05	22.14	1.91	0.25
Adipocyte - omental, donor2	11474-119C7	54.57	19.43	2.99	2.24
Adipocyte - omental, donor3	11475-119C8	111.53	16.41	4.02	0.00
Adipocyte - perirenal, donor1	11476-119C9	35.09	19.14	3.83	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	214.40	5.50	6.60	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	89.42	21.68	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	302.02	15.12	5.04	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	74.51	23.27	1.56	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	49.93	19.82	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	87.53	21.47	1.67	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	101.10	21.16	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	406.43	13.91	2.73	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	81.33	15.49	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	79.45	7.46	4.27	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	117.41	9.46	4.45	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	962.79	8.32	6.65	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	133.37	11.05	0.75	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	313.50	9.82	7.85	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	568.75	6.70	3.65	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	51.93	28.51	0.00	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	46.62	11.12	0.72	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	16.77	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	31.12	25.19	0.54	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	15.06	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	45.61	26.30	1.03	1.03
Anulus Pulposus Cell, donor1	11248-116E6	41.54	22.31	0.69	1.72
Anulus Pulposus Cell, donor2	11463-119B5	34.78	14.69	0.73	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	43.13	19.77	3.15	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	33.86	22.14	2.17	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	21.40	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	36.77	17.64	3.59	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	29.09	21.50	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	28.38	11.22	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	31.51	15.92	2.27	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	43.20	19.42	2.91	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	29.10	16.03	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	36.91	16.95	3.39	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.75	25.40	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	23.82	12.54	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	33.61	19.77	0.33	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	50.50	20.47	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.17	17.19	0.75	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	49.29	17.68	2.68	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	38.73	18.14	1.32	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	29.67	18.18	4.01	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	36.09	12.68	3.90	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	37.82	18.24	1.00	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	32.42	14.41	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	17.70	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	40.48	18.70	1.54	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	25.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	38.83	21.36	2.91	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.39	21.25	1.90	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	24.23	21.80	4.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	45.03	19.95	4.56	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	30.14	20.31	1.28	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	30.71	20.65	1.03	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	38.94	23.93	1.88	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	33.44	17.69	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.83	18.55	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	26.91	18.72	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	40.64	17.16	3.01	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	20.20	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	42.72	18.31	3.56	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	39.48	21.14	1.78	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	22.24	13.34	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	47.04	20.71	1.73	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	37.89	15.45	1.06	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	27.55	16.24	1.16	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	22.67	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	36.11	20.00	2.03	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	11.58	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	59.15	23.24	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	33.23	17.58	1.07	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.25	8.42	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	36.45	16.77	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	32.64	17.24	1.15	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	28.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	23.39	11.44	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	32.20	16.52	1.45	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.64	15.61	2.75	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	46.85	21.51	3.82	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	29.71	17.07	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	32.04	16.78	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	31.57	16.06	2.77	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	33.10	15.36	1.06	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	26.17	13.08	2.18	0.36
Astrocyte - cerebellum, donor1	11500-119F6	58.09	34.27	0.98	2.09
Astrocyte - cerebellum, donor2	11580-120F5	59.73	31.84	1.54	1.54
Astrocyte - cerebellum, donor3	11661-122F5	26.85	22.23	0.42	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	38.69	44.62	0.70	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	68.92	62.44	3.56	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	89.94	65.48	2.39	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	22.59	58.26	2.18	2.98
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	19.67	54.12	1.75	3.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	18.32	48.93	1.37	2.39
Basophils, donor1	12241-129G9	3.40	15.43	0.00	0.78
Basophils, donor2	12242-129H1	3.61	17.32	0.00	1.44
Basophils, donor3	12243-129H2	3.67	13.96	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	44.85	12.72	0.43	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	42.06	6.86	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	0.00	21.52	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	96.66	8.79	3.14	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	124.77	15.60	1.87	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	29.71	11.28	1.15	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	104.37	10.98	0.72	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	22.98	32.98	0.41	6.29
Burkitt's lymphoma cell line:RAJI	10476-106I8	57.06	48.91	1.63	3.73
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	4.80	30.38	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	2.25	10.71	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	2.41	11.14	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	4.17	14.05	0.44	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	4.81	21.79	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	3.41	13.65	0.00	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.26	18.41	0.00	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	5.20	8.53	0.58	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	6.03	6.64	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	6.63	10.90	0.24	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.52	8.54	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.97	4.42	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	8.18	5.95	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.13	6.85	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.45	5.52	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	3.92	5.01	0.65	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.62	7.26	0.23	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.92	7.39	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	3.33	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.76	7.88	0.45	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.59	2.99	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.66	7.70	0.21	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.58	9.61	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.11	2.71	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.60	3.93	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	3.77	9.68	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.19	3.49	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.05	10.94	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.76	8.08	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.34	4.23	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	9.65	4.39	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.23	5.75	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.72	5.20	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.82	7.98	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.83	6.14	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.01	3.01	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.35	5.10	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	2.40	18.53	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	3.00	21.71	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	3.90	16.68	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	4.83	27.41	0.93	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	3.32	21.66	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	4.01	23.63	1.34	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	4.08	18.37	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.29	18.22	0.88	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	4.63	14.32	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	28.45	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	3.39	27.12	0.68	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	14.50	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4.26	21.85	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	3.75	30.02	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.02	26.67	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.14	25.88	0.78	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	3.95	19.77	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	2.47	12.33	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	2.90	10.88	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	1.51	13.13	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	21.42	37.17	0.40	3.23
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	12.38	31.96	0.80	1.20
CD34+ Progenitors, donor1	11545-120B6	2.01	21.09	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.56	7.87	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	6.01	19.54	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	8.57	34.50	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	2.50	17.85	0.00	1.43
CD4+ T Cells, donor2	11306-117C1	3.06	21.43	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	5.49	24.09	0.91	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	4.34	33.44	0.77	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	3.14	30.55	0.45	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	4.60	27.02	0.00	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2.84	16.59	0.00	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	23.18	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	39.55	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	4.19	26.16	0.29	1.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	8.30	33.05	0.85	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	5.16	30.79	0.48	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	3.59	19.73	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	4.89	20.61	0.00	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	5.28	31.68	0.88	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	4.22	31.20	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	11.01	32.20	1.25	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	5.35	25.06	1.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.72	18.49	0.00	3.81
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1.61	20.90	0.00	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	21.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	4.26	41.54	0.74	1.67
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	6.07	28.59	0.65	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	3.99	32.15	1.05	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	6.07	22.75	1.01	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	3.47	26.43	0.87	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	4.36	29.20	0.00	3.49
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	4.95	32.66	0.49	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	4.62	22.16	0.92	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2.79	18.15	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	2.77	23.54	0.83	2.77
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	4.66	28.22	0.49	2.70
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	6.16	27.72	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	5.73	43.33	0.72	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	33.24	0.00	2.77
CD8+ T Cells, donor1	11226-116C2	4.26	21.61	0.00	2.62
CD8+ T Cells, donor2	11307-117C2	4.13	22.90	1.13	1.88
CD8+ T Cells, donor3	11383-118B6	4.54	18.43	0.00	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.24	16.29	0.69	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	10.78	14.86	0.96	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.86	19.15	0.55	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.61	23.72	1.20	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	11.52	13.44	0.72	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	9.32	14.55	0.23	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	21.29	17.82	0.43	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.58	14.74	0.79	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.24	15.71	1.88	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.81	21.43	2.72	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	17.72	20.63	0.87	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	18.65	17.85	1.33	3.73
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.14	14.01	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	36.43	10.47	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	46.24	5.22	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.44	14.41	1.44	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.37	12.37	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.25	12.49	1.18	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	17.75	16.80	0.63	3.17
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	16.30	17.22	0.31	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	11.22	16.03	0.32	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	11.86	12.62	0.76	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.43	8.67	0.39	3.55
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	8.32	11.35	1.51	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	44.97	8.83	0.00	7.23
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	46.86	2.80	0.70	9.79
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	45.08	10.02	0.00	8.01
Cardiac Myocyte, donor1	11525-119I4	10.97	21.93	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	35.57	18.28	0.49	1.48
Cardiac Myocyte, donor3	11686-122I3	77.14	26.62	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	22.88	14.21	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	14.22	16.35	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	13.65	11.95	1.14	0.11
Chondrocyte - re diff, donor2	11339-117F7	63.56	20.59	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	67.94	39.63	2.83	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	73.67	42.00	1.38	2.07
Ciliary Epithelial Cells, donor2	11323-117D9	111.16	47.03	5.13	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	128.06	34.16	3.19	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	19.44	27.14	0.37	2.38
Corneal Epithelial Cells, donor1	11526-119I5	48.09	14.05	0.66	0.44
Corneal Epithelial Cells, donor2	11606-120I4	56.88	15.93	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	63.40	13.55	1.02	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	3.96	18.33	0.33	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	7.25	16.40	0.32	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	24.15	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.20	19.22	0.32	1.40
Dendritic Cells - plasmacytoid, donor1	11228-116C4	5.81	26.31	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	5.22	28.07	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	2.90	16.94	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	53.20	35.02	0.50	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	36.97	21.12	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	41.85	31.11	0.57	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	36.57	24.77	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	30.25	17.16	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	43.53	30.82	5.18	0.24
Endothelial Cells - Artery, donor3	11413-118E9	69.07	34.36	2.45	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	40.34	25.05	0.89	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	39.55	19.78	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	32.14	20.30	0.28	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	49.32	24.66	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	27.60	22.39	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	27.36	22.83	1.42	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	61.62	32.41	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	26.21	33.02	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	74.18	51.93	2.24	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	77.78	35.85	1.09	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	89.89	46.65	0.37	0.85
Endothelial Cells - Vein, donor1	11267-116G7	64.84	38.68	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	66.36	35.62	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	66.10	41.92	1.73	0.00
Eosinophils, donor1	12244-129H3	0.00	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	14.85	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	17.83	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	69.88	11.73	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	6.24	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	53.78	25.86	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	28.80	6.02	1.86	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	24.16	15.82	2.60	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	51.67	29.83	0.97	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	118.46	28.39	1.64	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.60	19.41	2.32	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	65.35	28.72	2.63	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	47.17	22.92	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	42.19	29.49	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	101.57	33.35	2.27	1.52
Fibroblast - Cardiac, donor3	11417-118F4	48.10	15.30	1.10	0.47
Fibroblast - Cardiac, donor4	11452-119A3	62.44	21.22	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	56.60	23.22	1.90	0.25
Fibroblast - Cardiac, donor6	11460-119B2	77.16	31.08	2.58	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	82.67	25.73	1.34	1.47
Fibroblast - Choroid Plexus, donor2	11572-120E6	45.30	24.59	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	143.55	52.73	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	23.53	14.76	0.23	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	99.22	22.22	0.51	1.87
Fibroblast - Dermal, donor1	11269-116G9	68.32	18.55	2.11	0.47
Fibroblast - Dermal, donor2	11346-117G5	70.75	26.41	1.42	0.94
Fibroblast - Dermal, donor3	11418-118F5	77.97	26.84	1.33	0.00
Fibroblast - Dermal, donor4	11450-119A1	96.88	35.84	4.75	0.79
Fibroblast - Dermal, donor5	11454-119A5	84.78	37.33	2.44	0.87
Fibroblast - Dermal, donor6	11458-119A9	108.82	52.46	2.44	1.14
Fibroblast - Gingival, donor1	11237-116D4	128.89	21.86	0.83	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	29.61	26.20	1.31	0.26
Fibroblast - Gingival, donor2	11318-117D4	113.20	43.62	5.93	1.32
Fibroblast - Gingival, donor3	11394-118C8	72.13	15.76	1.35	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	27.01	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.15	16.56	1.76	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	37.88	32.27	0.78	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	41.11	27.05	1.49	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	32.11	17.64	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	45.19	25.59	0.73	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	32.18	23.86	1.50	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.75	28.19	1.54	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	21.13	26.12	0.88	0.29
Fibroblast - Lung, donor1	11270-116H1	127.78	28.55	5.44	0.00
Fibroblast - Lung, donor2	11347-117G6	41.78	32.83	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	71.12	43.90	1.69	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	114.96	21.66	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	97.90	12.59	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	28.27	7.56	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	158.73	46.28	0.41	1.22
Fibroblast - Mammary, donor2	11620-122A9	63.91	23.97	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	125.08	29.78	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	126.86	40.73	1.55	1.75
Fibroblast - Periodontal Ligament, donor2	11319-117D5	122.26	50.81	5.16	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	155.44	21.11	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	50.76	20.61	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	41.04	23.49	2.43	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.88	23.43	0.81	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	49.96	30.29	0.99	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	178.60	23.16	1.63	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	94.22	32.07	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	128.49	16.61	2.37	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	97.64	47.23	1.79	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	16.52	15.10	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	27.00	23.85	1.18	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	73.11	43.02	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	23.75	15.55	0.86	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	78.45	51.12	1.77	1.27
Fibroblast - skin normal, donor1	11553-120C5	24.45	21.33	0.33	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	108.67	60.75	1.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	43.00	29.94	2.01	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	99.13	54.70	1.81	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.98	21.95	0.41	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	17.10	17.95	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	97.22	29.23	2.30	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	53.79	24.39	1.38	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	33.90	35.09	1.52	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.23	13.33	2.35	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	15.69	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	82.69	10.23	0.87	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	78.07	13.53	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	127.25	13.03	0.51	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	52.06	51.29	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	60.62	39.56	3.19	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	55.63	65.61	2.57	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	30.61	67.28	1.65	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	27.63	37.67	0.91	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	47.15	57.85	3.17	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	27.23	65.56	2.38	3.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	40.44	47.62	1.30	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	39.80	40.68	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	28.12	41.41	1.55	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	19.83	37.80	0.86	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	21.22	34.12	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	28.12	43.24	2.23	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	23.81	43.60	1.11	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	26.84	30.50	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.62	41.30	1.14	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.55	34.50	1.12	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	27.10	28.41	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.59	31.91	1.18	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	15.74	32.75	1.59	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	17.20	25.25	0.67	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	12.90	39.12	2.22	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	17.30	43.94	1.87	1.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	21.81	44.78	1.06	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.67	55.98	0.42	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.83	47.65	0.51	1.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.93	38.62	1.44	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.46	40.68	0.75	1.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.46	32.87	0.41	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	15.06	42.71	1.03	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	13.14	42.31	1.15	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.68	35.52	1.17	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	8.16	35.71	2.65	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	10.70	42.06	1.35	2.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	22.86	33.39	1.13	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	11.87	34.96	1.28	2.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	12.51	35.34	0.38	1.23
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.19	36.22	0.95	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	11.86	35.27	1.52	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	12.34	42.86	1.67	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	14.49	29.64	1.10	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	11.78	36.75	0.84	2.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	23.89	34.91	0.37	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	20.59	33.43	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	25.70	37.64	1.84	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	28.63	30.57	0.52	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.43	29.00	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.25	32.81	0.74	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	18.64	29.17	1.10	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	12.89	19.83	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	18.86	30.47	1.45	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	29.66	31.07	2.62	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	8.90	31.77	0.25	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	35.43	39.41	1.19	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	19.72	41.14	1.69	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	37.44	69.15	0.82	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	56.95	39.43	1.56	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	45.21	38.43	0.85	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	50.27	56.73	0.46	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	27.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	47.96	47.19	3.09	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	48.13	28.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	53.90	5.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	50.77	30.92	2.28	2.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	47.36	37.89	4.12	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	33.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	47.82	33.56	1.40	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	49.68	39.22	3.27	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.11	44.46	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	60.12	44.21	2.54	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	56.72	43.82	4.08	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	66.82	41.76	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	64.14	50.97	5.73	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	62.75	45.29	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	50.82	44.05	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	77.87	50.12	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	64.44	54.31	2.76	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	10.54	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	71.12	33.83	2.69	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	56.39	28.03	1.63	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	58.86	19.40	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	52.78	44.69	5.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	65.04	37.66	2.74	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	34.79	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	48.13	38.22	4.72	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.30	36.81	2.41	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	41.71	40.19	2.54	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	51.05	37.89	2.79	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	64.63	35.03	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	44.86	49.58	1.18	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	46.68	36.17	3.50	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	73.29	35.99	2.19	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	36.45	38.99	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	40.59	29.85	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	57.74	29.60	3.40	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	41.09	20.54	3.42	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	32.85	18.71	1.66	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	51.72	38.23	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	32.98	19.66	1.27	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	105.27	12.53	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	136.81	21.12	4.99	2.55
Hep-2 cells mock treated, biol_rep2	11899-125E9	145.00	18.23	6.08	1.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	147.65	19.11	4.55	2.05
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	137.51	19.57	4.37	2.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	128.95	20.42	2.79	2.58
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	138.21	17.87	2.58	3.01
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	146.46	17.44	5.36	3.24
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	136.90	17.33	3.60	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	155.06	16.98	5.13	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	53.72	25.74	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	33.76	27.70	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	18.51	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	105.82	31.04	1.06	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	64.66	30.51	0.73	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	75.01	31.12	2.62	0.00
Hepatocyte, donor1	11523-119I2	21.79	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	24.78	14.01	0.00	0.00
Hepatocyte, donor3	11684-122I1	22.70	11.04	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.89	60.70	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	80.92	30.59	1.40	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	98.93	23.19	0.41	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	70.05	98.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	40.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	56.76	76.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	27.53	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	59.34	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	61.51	76.89	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	45.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	58.48	68.22	4.87	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	40.02	51.69	1.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	39.94	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	76.76	76.76	1.32	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	56.54	54.32	3.33	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	36.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	40.31	55.43	3.15	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	46.40	86.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	43.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	47.16	65.90	2.58	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	66.01	72.45	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	57.86	73.34	1.63	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	55.00	85.64	2.94	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	57.49	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	57.87	66.71	3.21	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	60.01	60.94	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	45.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	50.98	57.59	1.42	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	42.63	62.58	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	58.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	67.80	57.03	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	72.42	73.69	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	65.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	55.48	75.88	5.10	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	85.67	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	31.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	57.13	77.12	2.86	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	79.64	99.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	41.98	62.97	1.85	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	45.66	68.48	3.51	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	69.15	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	57.02	96.66	0.70	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	48.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	35.66	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	22.67	45.34	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	38.25	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	48.78	34.85	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	25.60	1.07	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	67.89	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	68.39	65.54	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	56.15	53.38	6.44	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	39.33	0.00	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	43.46	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	23.26	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	239.00	12.73	4.00	0.41
Keratinocyte - epidermal, donor2	11349-117G8	35.72	8.20	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	156.84	10.51	3.03	0.19
Keratinocyte - oral, donor1	11251-116E9	72.31	30.76	1.25	0.45
Keratocytes, donor1	11527-119I6	14.10	11.00	0.34	1.38
Keratocytes, donor2	11607-120I5	128.90	25.78	3.52	1.17
Keratocytes, donor3	11688-122I5	11.86	14.62	0.20	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	10.99	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	66.88	28.05	3.24	0.00
Lens Epithelial Cells, donor2	11609-120I7	62.39	33.68	0.46	1.50
Lens Epithelial Cells, donor3	11690-122I7	81.74	26.03	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	35.45	33.68	0.83	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	18.98	20.65	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	29.91	31.17	1.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	24.20	23.12	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.69	25.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.23	23.50	0.97	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.16	20.93	1.64	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.19	19.97	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.69	23.22	0.99	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.99	14.24	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	17.26	20.36	0.78	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	18.89	24.44	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.86	18.81	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	17.89	19.32	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.39	27.88	0.55	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	25.25	23.71	1.54	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	17.77	20.58	1.25	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.90	25.98	1.46	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	26.33	20.08	1.97	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	18.74	28.70	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	24.40	24.15	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	25.22	16.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.50	21.81	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	21.65	28.31	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	18.14	18.66	1.56	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.68	18.01	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	21.95	24.36	0.90	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	19.26	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.25	20.13	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	19.83	28.10	0.85	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	19.87	23.26	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	19.19	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	18.96	24.41	1.24	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.25	21.10	1.85	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.03	17.54	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.70	21.17	1.10	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	22.51	23.16	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.00	16.43	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.99	20.99	0.70	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.24	17.78	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	13.09	19.88	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	19.14	22.41	0.93	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.28	19.34	0.72	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	24.17	18.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.78	18.13	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	31.19	33.91	0.74	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	20.49	16.39	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.18	18.80	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	6.80	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	46.80	11.51	1.53	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	31.92	7.42	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	29.62	14.39	1.69	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.73	12.66	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	32.69	7.47	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	25.76	11.85	5.15	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	45.20	13.08	0.00	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	25.11	15.61	0.45	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	28.21	12.21	4.36	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	30.16	13.06	1.80	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	36.85	17.07	0.95	1.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	28.76	13.87	5.14	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	35.29	14.47	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	20.66	10.66	0.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	31.07	12.23	2.04	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	29.62	12.01	1.07	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	33.82	14.17	3.02	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	29.45	14.73	3.07	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	43.22	25.28	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	31.44	17.08	2.50	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	29.99	16.26	3.36	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	37.09	10.30	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	40.35	16.26	5.52	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	26.60	16.44	1.79	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	33.75	15.49	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	39.24	23.33	2.47	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	28.76	15.86	3.69	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	42.60	8.06	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	37.22	19.19	3.84	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	36.23	13.02	4.53	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	47.59	11.49	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	40.22	17.17	3.62	3.16
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	35.19	12.93	1.44	5.03
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	35.85	10.46	1.49	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	34.19	19.32	6.69	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	26.28	16.80	4.31	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	31.68	13.70	4.28	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	41.31	18.99	3.66	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	30.77	9.05	3.02	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	41.95	17.06	1.42	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	34.37	17.53	2.41	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	27.37	10.73	3.22	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	43.77	18.85	1.35	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	42.23	12.59	3.70	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	25.58	11.63	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	28.56	15.87	2.12	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	40.82	15.21	3.20	2.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	26.17	16.72	2.18	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.22	18.40	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	42.42	15.29	2.47	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	22.58	7.53	2.82	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	46.26	15.08	2.51	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	32.44	18.48	2.70	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	13.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	49.43	16.03	1.34	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	39.10	19.16	3.13	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.97	9.24	3.30	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	48.26	12.45	1.04	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	37.63	17.94	3.50	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.87	10.62	3.35	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	49.91	16.78	1.77	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	48.21	15.81	1.93	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	29.37	18.74	2.03	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.58	19.22	1.92	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	36.57	15.90	3.58	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	21.87	12.15	3.65	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	47.73	8.99	2.08	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	40.28	17.10	1.52	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	36.67	16.53	4.13	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	47.77	13.30	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	41.20	20.60	3.80	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	41.05	17.59	0.53	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	40.80	8.62	1.72	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	48.34	18.51	2.06	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	48.10	12.73	2.83	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	49.37	10.78	1.13	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	52.84	18.72	2.50	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	35.24	21.93	3.13	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	51.36	12.94	2.09	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	52.50	13.01	4.18	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	35.46	12.71	3.35	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	51.86	18.18	2.14	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	42.83	24.25	5.25	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	33.04	18.36	2.75	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	37.34	5.33	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	53.57	21.09	3.42	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	44.48	16.10	3.83	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	53.08	14.77	3.83	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	63.25	15.59	2.67	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	44.97	20.54	1.30	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	65.65	13.93	1.33	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	62.36	20.79	6.24	4.16
Macrophage - monocyte derived, donor1	11232-116C8	4.56	15.73	0.23	1.14
Macrophage - monocyte derived, donor2	11313-117C8	6.97	18.17	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	15.07	24.25	0.52	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	84.96	7.97	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	102.04	20.76	1.74	0.63
Mallassez-derived cells, donor3	11930-125I4	101.88	16.54	1.95	0.83
Mammary Epithelial Cell, donor1	11273-116H4	19.73	12.65	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	50.67	15.64	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	103.26	16.46	1.00	0.00
Mast cell - stimulated, donor1	11487-119E2	22.37	32.54	0.00	2.71
Mast cell, donor1	11563-120D6	13.52	29.52	0.32	4.54
Mast cell, donor2	11565-120D8	7.43	25.85	1.19	0.30
Mast cell, donor3	11566-120D9	4.73	27.24	0.00	1.35
Mast cell, donor4	11567-120E1	6.56	22.34	0.71	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	5.10	29.83	0.55	4.66
Mast cell, expanded and stimulated, donor8	11942-126A7	8.17	23.35	0.00	2.33
Mast cell, expanded, donor5	11939-126A4	5.74	29.71	0.69	3.56
Mast cell, expanded, donor8	11941-126A6	12.55	34.14	0.84	2.34
Melanocyte - dark, donor1	11502-119F8	43.58	23.28	0.60	0.00
Melanocyte - dark, donor2	11582-120F7	42.91	24.23	2.42	0.00
Melanocyte - dark, donor3	11663-122F7	53.39	40.64	0.29	0.87
Melanocyte - light, donor1	11274-116H5	23.74	24.92	0.24	0.47
Melanocyte - light, donor2	11351-117H1	27.30	32.76	0.00	1.36
Melanocyte - light, donor3	11423-118G1	64.17	17.34	1.73	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	28.63	31.86	2.08	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	39.80	30.39	1.08	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	58.39	26.25	0.80	1.87
Meningeal Cells, donor1	11493-119E8	101.36	48.26	1.61	0.87
Meningeal Cells, donor2	11573-120E7	96.83	35.21	1.32	2.64
Meningeal Cells, donor3	11654-122E7	64.30	50.94	1.47	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	97.24	45.34	2.00	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	41.26	12.38	0.30	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	38.11	9.20	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	70.64	23.55	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	46.64	33.01	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	44.68	19.91	1.06	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	49.76	13.57	2.01	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	125.48	38.24	1.54	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	91.32	36.53	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	71.61	31.10	0.82	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	39.20	13.85	0.28	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	33.46	15.24	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	166.05	26.18	1.71	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.13	13.65	0.59	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	169.71	32.66	3.20	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	59.55	43.24	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	188.26	21.58	1.88	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	60.23	37.01	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	46.41	23.07	1.59	1.33
Mesothelial Cells, donor2	12156-128G5	33.03	11.01	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	42.13	16.77	1.45	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	8.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.07	17.98	0.49	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.95	13.25	0.88	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	27.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.09	16.12	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.64	9.96	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	16.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	9.26	13.01	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.52	13.03	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.32	16.05	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5.54	12.27	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	25.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	6.19	7.96	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.74	11.02	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	18.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.22	15.92	0.64	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	8.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6.56	7.75	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	13.41	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	67.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.53	9.53	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.74	9.74	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	17.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.60	11.05	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.31	9.89	0.42	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.80	12.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.01	13.30	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.56	11.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.32	10.07	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.07	7.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.88	11.69	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	12.35	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	6.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.61	7.69	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.61	10.41	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	17.83	13.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.51	8.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	6.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.44	9.20	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	6.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	9.61	16.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.67	12.89	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	10.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	26.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	15.04	14.70	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.07	15.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.27	23.79	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	21.60	18.52	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.05	14.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.40	19.23	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.69	23.53	1.21	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.95	14.19	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	28.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	24.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.94	16.50	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	28.19	22.25	0.41	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	30.06	20.73	0.78	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	14.59	21.88	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	16.51	15.24	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.88	15.75	0.00	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.17	17.96	1.20	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.98	17.09	0.71	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.30	19.11	0.64	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	17.47	19.46	0.44	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	21.99	17.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	23.30	18.75	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	17.21	18.19	0.25	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	18.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.94	17.94	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	11.24	20.18	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	5.77	10.72	0.41	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.74	15.48	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	15.07	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	7.13	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.57	18.73	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	14.73	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.73	13.64	0.20	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1.86	8.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.88	9.01	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.59	12.78	1.33	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	3.62	10.86	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	6.63	8.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.23	18.32	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	9.33	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	5.88	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	11.59	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	12.12	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.11	5.06	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	2.72	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	4.53	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	371.16	11.42	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	192.48	13.05	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	80.79	4.75	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	188.24	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	50.20	24.13	0.86	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	30.83	13.59	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	42.72	22.69	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	33.39	24.21	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	42.78	52.67	0.76	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	30.32	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	15.64	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	11.03	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	27.62	16.32	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	66.24	32.31	0.93	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	34.05	17.83	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	34.27	15.98	0.42	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	53.11	14.89	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	13.26	15.97	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	62.11	15.64	1.59	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	26.45	14.70	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.16	18.41	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	20.69	11.67	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	25.21	7.80	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.85	13.78	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	36.59	11.71	0.65	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	27.69	16.58	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.99	9.85	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.09	12.87	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.67	16.07	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.18	20.00	1.03	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	12.64	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.17	15.37	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.67	14.40	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.85	22.31	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	22.32	15.02	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.33	21.66	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	20.29	14.88	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.62	10.71	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	20.43	17.64	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	21.95	17.78	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	29.98	16.29	1.30	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.28	10.89	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	14.93	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	32.63	10.58	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	22.60	10.64	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.90	14.88	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	24.12	13.78	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.91	24.80	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	32.93	14.59	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	20.33	13.55	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	8.54	14.63	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.98	17.31	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.15	17.25	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	20.57	11.08	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	10.20	11.34	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	62.36	15.53	1.61	1.12
Myoblast, donor2	11322-117D8	46.22	26.47	3.84	0.38
Myoblast, donor3	11398-118D3	52.80	18.33	0.34	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	22.33	50.20	0.29	2.92
Natural Killer Cells, donor1	11230-116C6	4.00	21.53	0.31	2.15
Natural Killer Cells, donor2	11311-117C6	4.82	18.09	1.81	2.41
Natural Killer Cells, donor3	11387-118C1	6.63	24.85	0.18	2.02
Neural stem cells, donor1	11275-116H6	25.04	56.26	1.45	2.18
Neural stem cells, donor2	11352-117H2	30.81	57.77	0.00	0.00
Neurons, donor1	11494-119E9	35.27	44.38	3.41	0.00
Neurons, donor2	11574-120E8	24.88	63.19	0.66	1.10
Neurons, donor3	11655-122E8	27.95	48.51	4.11	0.00
Neutrophils, donor1	11233-116C9	8.35	17.63	0.93	0.00
Neutrophils, donor2	11314-117C9	11.60	31.89	0.00	0.00
Neutrophils, donor3	11390-118C4	4.28	23.21	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	16.39	26.36	0.71	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	38.10	16.61	1.63	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	28.48	14.84	1.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	11.43	20.65	0.69	0.28
Olfactory epithelial cells, donor2	11934-125I8	17.51	18.38	2.89	0.14
Olfactory epithelial cells, donor3	11935-125I9	12.60	14.30	0.57	0.34
Olfactory epithelial cells, donor4	11936-126A1	14.22	22.11	0.39	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	113.14	30.69	1.20	1.20
Osteoblast - differentiated, donor1	11276-116H7	15.95	16.38	0.64	0.64
Osteoblast - differentiated, donor2	11353-117H3	25.15	17.15	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	40.97	13.03	0.62	0.00
Osteoblast, donor1	11277-116H8	88.73	36.35	1.17	0.78
Osteoblast, donor2	11354-117H4	46.35	27.39	0.00	0.00
Osteoblast, donor3	11426-118G4	71.27	43.01	1.60	0.53
Pancreatic stromal cells, donor1	11249-116E7	55.26	26.11	0.76	0.25
Pericytes, donor1	11491-119E6	50.40	16.36	0.89	1.45
Pericytes, donor2	11571-120E5	36.22	12.22	0.91	0.91
Pericytes, donor3	11652-122E5	81.18	29.50	2.44	0.41
Perineurial Cells, donor1	11499-119F5	83.75	34.02	0.45	0.57
Perineurial Cells, donor2	11579-120F4	49.59	28.62	0.37	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	2.23	24.22	0.64	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1.71	21.55	1.71	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	4.01	24.07	0.39	0.39
Placental Epithelial Cells, donor1	11278-116H9	10.76	10.04	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	17.74	7.76	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	17.67	20.42	0.59	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.00	17.72	3.16	0.00
Preadipocyte - breast, donor1	11467-119B9	35.08	17.63	0.75	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	116.82	62.13	0.91	0.65
Preadipocyte - breast, donor2	11328-117E5	45.71	30.40	4.50	0.90
Preadipocyte - omental, donor1	11468-119C1	39.96	23.44	1.28	0.32
Preadipocyte - omental, donor2	11329-117E6	30.12	15.71	1.75	0.44
Preadipocyte - omental, donor3	11403-118D8	76.64	29.37	1.86	0.57
Preadipocyte - perirenal, donor1	11469-119C2	60.04	20.67	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	104.11	31.33	0.61	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	65.87	35.42	6.20	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	64.20	28.61	1.87	0.68
Preadipocyte - visceral, donor1	11280-116I2	48.44	27.66	0.09	0.37
Preadipocyte - visceral, donor2	11357-117H7	33.13	28.99	4.14	0.00
Preadipocyte - visceral, donor3	11429-118G7	38.66	20.69	2.09	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	80.10	31.98	1.36	1.21
Prostate Epithelial Cells, donor2	11331-117E8	77.86	10.97	5.28	0.27
Prostate Epithelial Cells, donor3	11404-118D9	11.70	10.23	0.12	0.67
Prostate Stromal Cells, donor1	11254-116F3	48.64	30.53	1.37	0.00
Prostate Stromal Cells, donor2	11332-117E9	42.14	19.18	4.30	0.18
Prostate Stromal Cells, donor3	11405-118E1	33.37	19.71	2.09	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	103.29	40.88	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	79.02	50.18	1.39	0.62
Renal Epithelial Cells, donor1	11517-119H5	64.93	32.46	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	64.02	54.77	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	69.34	56.64	1.16	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	59.91	25.19	3.40	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	75.06	29.78	2.43	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	48.84	32.41	2.89	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	17.30	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	134.03	36.09	0.88	1.10
Renal Mesangial Cells, donor2	11598-120H5	132.92	45.77	4.39	1.88
Renal Mesangial Cells, donor3	11679-122H5	107.91	30.24	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	87.77	46.17	0.54	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	62.83	23.19	1.27	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	85.82	56.50	1.93	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	137.42	34.74	1.04	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	76.18	31.55	0.28	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	84.39	24.70	3.09	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.28	18.32	0.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	8.82	18.04	0.40	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	9.83	15.19	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.31	22.01	0.55	6.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	10.44	24.94	1.16	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	24.83	28.35	1.95	1.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	29.89	44.19	1.89	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	30.00	42.16	0.33	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	37.71	40.07	0.99	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.97	41.72	2.80	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	24.96	39.75	1.62	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	27.66	26.56	0.41	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	27.23	41.00	1.82	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	30.28	35.84	0.00	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	34.14	26.83	1.43	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	30.05	39.06	2.36	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	26.33	42.48	1.33	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	30.59	20.07	1.15	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	29.35	40.71	1.02	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.80	44.72	1.13	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	32.91	32.65	0.00	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.26	43.12	2.34	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	30.17	39.15	1.34	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	30.22	29.37	0.75	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.42	41.20	2.24	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	32.81	42.90	1.03	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	29.17	26.44	0.55	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.12	44.02	1.47	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	41.24	45.67	2.15	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	34.91	28.54	0.47	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	29.37	41.47	1.98	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	40.46	42.09	1.64	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	41.06	22.39	0.83	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.78	52.21	3.98	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	35.51	43.45	0.42	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	36.47	31.76	1.08	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	31.85	42.91	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	39.33	43.57	1.74	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	36.11	24.76	1.55	3.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	28.26	43.21	0.69	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	34.48	38.42	2.13	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	34.77	25.56	1.70	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.96	44.24	0.44	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	31.72	31.45	0.27	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.02	25.03	0.28	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.14	48.57	0.71	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	29.83	45.55	0.81	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.75	27.50	0.75	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	17.47	32.84	2.10	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	14.20	27.50	0.60	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	20.81	25.58	0.73	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	13.10	37.70	0.15	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	16.43	34.07	0.00	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	26.52	25.02	0.60	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	13.12	35.96	1.36	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	11.38	30.25	0.90	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	11.93	20.90	0.83	2.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	14.09	31.59	1.28	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	9.01	34.86	0.00	3.00
Schwann Cells, donor1	11498-119F4	57.36	40.06	1.50	0.75
Schwann Cells, donor2	11578-120F3	17.01	27.22	0.00	0.00
Schwann Cells, donor3	11659-122F3	94.86	35.27	4.38	0.22
Sebocyte, donor1	11220-116B5	151.73	23.55	0.55	0.00
Sebocyte, donor2	11301-117B5	103.40	15.62	4.14	0.46
Sebocyte, donor3	11378-118B1	73.17	17.31	2.27	0.21
Sertoli Cells, donor1	11255-116F4	61.29	26.51	4.97	0.00
Sertoli Cells, donor2	11333-117F1	25.42	19.77	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	16.63	24.02	0.26	0.35
Skeletal Muscle Cells, donor2	11358-117H8	18.79	10.84	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	46.82	42.64	3.34	0.00
Skeletal Muscle Cells, donor4	11451-119A2	70.22	33.15	2.51	0.79
Skeletal Muscle Cells, donor5	11455-119A6	84.58	28.99	2.97	0.59
Skeletal Muscle Cells, donor6	11459-119B1	86.19	46.02	2.15	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	117.56	34.65	2.27	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	113.44	37.10	4.57	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	80.66	43.06	2.38	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	44.06	25.78	0.51	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.12	26.78	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	91.64	37.15	3.85	0.41
Skin - palm, donor1	10286-104F7	10.74	16.12	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	39.07	9.08	2.31	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	105.51	24.54	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	40.51	10.52	1.56	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	23.21	13.34	0.83	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	19.55	13.08	0.84	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	119.89	23.89	0.21	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	12.59	10.27	0.07	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	46.90	12.03	2.47	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	112.05	31.35	2.67	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	77.59	32.92	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	49.72	19.89	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	81.51	29.14	0.00	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	69.53	36.31	0.77	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	16.01	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	90.63	29.68	0.80	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	51.87	27.04	2.22	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	55.95	19.46	1.15	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	140.00	20.19	1.30	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	104.25	20.08	0.89	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	108.05	17.23	1.99	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	70.93	11.71	0.98	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.01	14.31	0.91	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	29.04	30.81	0.76	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	18.36	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	62.94	26.70	2.86	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	91.43	19.61	1.62	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	126.78	19.59	5.81	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	159.75	26.97	2.83	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	83.99	29.70	0.31	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	77.61	20.48	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	58.58	28.99	0.60	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	70.67	21.51	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	71.30	23.79	0.47	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	42.07	31.00	1.91	1.71
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	41.19	18.20	1.59	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	60.98	28.98	3.62	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	59.08	37.09	0.53	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	53.80	16.51	0.27	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	80.77	20.79	4.63	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	42.62	13.70	1.01	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	67.40	38.15	1.06	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	21.00	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	38.77	25.84	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	76.74	33.95	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	44.43	17.67	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	42.31	16.92	2.19	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	84.96	11.50	0.88	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	85.72	37.82	0.08	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	97.17	26.63	2.80	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	58.43	31.23	0.43	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	71.13	34.16	1.53	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	66.75	36.29	1.13	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	174.12	36.75	0.56	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	128.70	28.15	1.26	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	26.19	8.57	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	62.39	27.65	1.22	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	84.62	20.33	1.77	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	45.64	16.97	0.88	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.22	10.88	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	30.68	13.49	1.85	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.65	9.67	1.86	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	23.36	12.94	2.16	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	48.26	12.21	1.42	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.88	16.54	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	14.22	11.17	0.76	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	10.78	11.58	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	16.72	14.21	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	22.00	9.63	1.38	0.00
Synoviocyte, donor1	11291-117A4	22.89	19.86	1.51	0.50
Synoviocyte, donor2	11368-117I9	9.89	17.27	0.67	0.00
Synoviocyte, donor3	11440-118H9	9.61	10.72	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	116.49	32.52	1.79	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	43.60	9.91	1.98	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	62.05	29.41	0.93	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	53.69	11.97	0.50	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	94.32	14.30	1.55	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	53.83	14.32	2.29	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	10.09	15.26	0.12	1.11
Urethra, donor2	10319-105A4	1.80	23.38	0.00	0.00
Urothelial Cells, donor1	11520-119H8	52.34	11.42	0.53	0.00
Urothelial Cells, donor2	11600-120H7	46.47	11.62	0.80	0.00
Urothelial Cells, donor3	11681-122H7	32.78	15.13	0.69	0.23
Urothelial cells, donor0	11216-116B1	57.73	26.97	1.11	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.01	16.91	0.89	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	10.01	17.16	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	5.48	24.64	0.68	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	6.54	22.73	1.03	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	5.81	13.94	0.00	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	3.12	23.95	0.00	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	5.51	21.11	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	4.56	11.87	1.83	3.65
Wilms' tumor cell line:G-401	10809-111A8	38.61	25.17	0.99	1.36
Wilms' tumor cell line:HFWT	10597-108E3	7.04	25.52	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	14.52	17.32	0.00	0.00
achilles tendon, donor2	10292-104G4	16.53	10.33	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	17.85	44.62	1.53	4.59
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	27.63	59.67	0.93	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	14.72	47.96	0.59	2.02
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	28.57	50.34	1.90	2.45
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	14.34	48.35	2.25	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	13.11	46.10	0.21	1.90
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	19.87	20.14	1.09	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	28.20	37.45	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	18.78	44.51	0.82	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	28.73	65.23	0.39	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.66	38.46	2.21	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	39.01	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	20.45	49.50	2.09	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.94	47.12	2.59	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.03	30.69	1.46	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	12.08	32.07	1.39	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.68	50.17	0.82	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.94	46.04	0.61	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	36.70	52.49	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	30.63	46.10	0.00	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	25.76	58.01	1.20	2.17
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	21.61	24.06	2.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	26.35	26.35	1.00	3.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	13.01	66.90	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	11.30	16.95	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	12.65	39.25	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	15.00	43.11	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	38.15	22.84	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	10.39	21.10	0.62	0.31
adipose, donor1	10184-103D4	15.25	61.57	0.59	4.10
adipose, donor2	10185-103D5	4.46	18.25	0.81	2.84
adipose, donor3	10186-103D6	16.88	31.86	0.82	1.63
adipose, donor4	10187-103D7	23.40	41.60	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	41.51	38.19	0.63	5.37
adrenal gland, adult, pool1	10081-102A9	29.10	18.19	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	18.28	41.89	0.40	2.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.51	45.02	1.79	0.71
amniotic membrane cells, donor1	12235-129G3	5.33	14.37	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	2.37	13.52	0.00	1.35
amniotic membrane cells, donor3	12237-129G5	3.54	9.13	0.29	0.88
amygdala - adult, donor10196	10167-103B5	10.67	13.04	1.19	0.00
amygdala, adult, donor10252	10151-102I7	8.52	20.07	0.61	4.87
amygdala, newborn, donor10223	10360-105E9	17.75	20.66	0.32	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	13.88	17.70	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	26.03	32.21	0.22	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	20.38	55.45	1.00	1.67
aorta, adult, pool1	10052-101G7	10.98	22.95	0.20	0.59
appendix, adult	10189-103D9	21.73	25.23	1.55	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	138.61	63.97	1.72	2.06
artery, adult	10190-103E1	5.43	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	15.07	29.12	0.58	1.59
b cell line:RPMI1788	10427-106D4	20.37	26.91	0.30	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	22.47	26.63	0.83	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	43.36	26.99	0.69	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	10.04	8.70	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.07	25.17	0.00	0.56
bladder, adult, pool1	10011-101C2	9.34	18.47	0.33	0.33
blood, adult, pool1	10053-101G8	2.21	19.93	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	15.41	0.00	0.00
bone marrow, adult	10192-103E3	4.72	21.59	3.37	1.35
brain, adult, donor1	10084-102B3	24.60	28.70	0.00	4.10
brain, adult, pool1	10012-101C3	5.68	28.06	0.56	2.00
brain, fetal, pool1	10085-102B4	24.04	85.48	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	7.27	17.84	0.99	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	91.25	13.11	0.25	0.37
breast, adult, donor1	10080-102A8	13.26	22.73	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	37.22	18.42	1.02	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	8.66	36.18	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	45.58	41.90	2.76	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	17.91	14.53	0.24	1.21
carcinoid cell line:NCI-H1770	10703-109H1	49.84	49.37	1.41	7.05
carcinoid cell line:NCI-H727	10735-110B6	6.13	11.38	0.00	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	45.32	45.32	0.63	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	49.51	51.90	3.19	3.99
caudate nucleus - adult, donor10196	10177-103C6	24.18	23.03	0.00	3.45
caudate nucleus, adult, donor10252	10164-103B2	17.23	20.75	0.67	5.02
caudate nucleus, adult, donor10258	10379-105H1	16.81	13.75	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	12.45	14.65	0.00	1.10
cerebellum - adult, donor10196	10173-103C2	26.22	23.31	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	13.02	19.22	0.21	10.68
cerebellum, adult, pool1	10083-102B2	12.76	20.35	0.00	3.45
cerebellum, newborn, donor10223	10357-105E6	15.78	20.76	0.00	4.98
cerebral meninges, adult	10188-103D8	5.55	23.70	0.25	1.51
cerebrospinal fluid, donor2	10294-104G6	12.43	10.96	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	16.10	40.40	0.43	1.29
cervical cancer cell line:ME-180	10553-107I4	18.23	13.42	0.50	0.66
cervix, adult, pool1	10013-101C4	7.56	20.37	0.52	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.62	17.70	0.28	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	28.74	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	26.97	50.08	0.87	0.50
choriocarcinoma cell line:SCH	10785-110H2	54.46	15.89	1.23	2.59
choriocarcinoma cell line:T3M-3	10618-108G6	29.17	26.09	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	9.69	15.39	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	15.71	22.77	0.89	0.89
chorionic membrane cells, donor3	12240-129G8	4.40	19.78	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	9.09	27.26	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	18.83	39.57	0.58	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	32.10	36.96	0.84	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	45.45	41.86	1.80	2.31
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	49.59	44.51	0.48	3.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	40.72	39.91	1.22	3.05
chronic myelogenous leukemia cell line:K562	10454-106G4	16.20	45.05	0.88	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	70.11	60.73	0.78	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	41.37	68.80	6.86	0.00
clear cell carcinoma cell line:TEN	10636-108I6	7.81	9.89	0.35	0.35
colon carcinoma cell line:CACO-2	10513-107D9	66.63	39.17	1.28	0.73
colon carcinoma cell line:COLO-320	10420-106C6	17.86	69.55	1.14	1.14
colon, adult, donor1	10082-102B1	11.90	28.56	1.19	2.38
colon, adult, pool1	10014-101C5	19.98	17.74	0.59	0.35
colon, fetal, donor1	10070-101I7	8.65	11.12	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4.58	50.42	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	8.07	8.07	1.27	5.95
cord blood derived cell line:COBL-a 24h infection	10453-106G3	19.02	26.56	0.60	3.02
cord blood derived cell line:COBL-a untreated	10449-106F8	15.23	27.22	1.13	3.38
corpus callosum, adult, pool1	10042-101F6	20.56	28.53	0.55	4.53
cruciate ligament, donor2	10295-104G7	28.37	12.97	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	16.85	12.04	0.00	0.00
diencephalon, adult	10193-103E4	13.44	15.60	0.48	2.40
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.49	56.71	4.59	2.98
ductal cell carcinoma cell line:KLM-1	10438-106E6	6.15	14.10	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	71.49	17.81	0.24	1.44
ductus deferens, adult	10196-103E7	9.97	17.94	0.50	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	30.24	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	19.86	26.48	3.68	0.74
dura mater, adult, donor1	10041-101F5	7.02	23.45	0.25	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	47.52	33.31	1.11	3.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	50.73	66.34	1.29	4.73
embryonic pancreas cell line:1B2C6	10604-108F1	9.25	29.60	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	9.08	34.51	2.12	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.64	28.40	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	17.08	28.90	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	49.61	52.29	1.68	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	2.90	14.50	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	31.04	32.16	4.02	1.13
epidermoid carcinoma cell line:A431	10426-106D3	26.90	15.23	0.00	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	56.42	37.94	0.55	0.88
epididymis, adult	10197-103E8	16.54	21.98	1.47	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	4.97	15.26	0.89	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	6.69	11.01	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	87.02	20.18	2.75	1.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	69.68	18.80	1.18	1.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	94.44	20.73	2.24	1.01
esophagus, adult, pool1	10015-101C6	13.27	16.67	0.32	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	5.51	20.16	0.25	0.63
eye - muscle inferior rectus, donor1	10272-104E2	2.41	24.15	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	12.63	10.52	0.00	0.00
eye - muscle medial, donor2	10299-104H2	4.46	22.32	0.00	0.00
eye - muscle superior, donor2	10297-104G9	11.46	12.61	1.15	4.59
eye - vitreous humor, donor1	10268-104D7	5.83	11.66	0.00	2.91
eye, fetal, donor1	10054-101G9	10.17	17.54	0.00	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	31.67	30.26	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	21.84	28.97	0.71	0.00
frontal lobe, adult, pool1	10040-101F4	9.95	26.18	0.00	2.06
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.81	21.62	0.30	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	16.18	43.25	0.37	1.37
gall bladder, adult	10198-103E9	21.25	21.25	1.45	0.48
gamma delta positive T cells, donor1	11937-126A2	1.61	31.67	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	3.36	33.24	0.00	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	23.23	21.97	1.06	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.12	25.72	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	45.74	41.81	0.33	5.41
gastric cancer cell line:GSS	10560-108A2	4.58	34.78	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	33.13	18.05	2.51	3.20
giant cell carcinoma cell line:LU65	10487-107B1	3.90	12.51	0.23	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	9.10	33.45	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	8.23	10.48	0.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	51.09	25.86	0.74	2.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	70.08	33.14	0.84	1.69
glioblastoma cell line:T98G	10485-107A8	24.17	38.30	0.44	0.55
glioma cell line:GI-1	10413-106B8	43.05	28.12	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	25.51	14.58	0.00	1.46
globus pallidus, adult, donor10252	10161-103A8	18.55	27.83	0.73	10.01
globus pallidus, adult, donor10258	10367-105F7	10.95	12.32	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	22.92	11.19	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	12.24	66.07	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	32.79	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	22.72	31.36	1.92	0.96
hIPS +CCl2, biol_rep1	14383-156B9	40.40	26.63	0.46	0.92
hIPS +CCl2, biol_rep2	14384-156C1	41.61	27.89	0.91	1.37
hIPS +CCl2, biol_rep3	14385-156C2	48.31	16.75	1.93	1.29
hIPS, biol_rep1	14380-156B6	23.00	10.06	0.00	2.87
hIPS, biol_rep2	14381-156B7	39.78	12.35	0.00	0.69
hIPS, biol_rep3	14382-156B8	27.59	16.55	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	10.34	29.60	0.57	1.44
heart - mitral valve, adult	10205-103F7	17.34	19.43	0.90	0.60
heart - pulmonic valve, adult	10206-103F8	10.98	11.77	0.00	1.31
heart - tricuspid valve, adult	10207-103F9	9.99	14.15	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	10.00	19.39	2.04	1.22
heart, adult, diseased, donor1	10051-101G6	5.54	14.48	0.85	1.28
heart, adult, pool1	10016-101C7	7.59	15.41	0.00	0.23
heart, fetal, pool1	10046-101G1	9.04	19.82	0.31	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	54.61	37.02	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	16.65	30.92	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	113.92	40.88	3.43	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	135.09	54.98	5.10	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	110.75	56.29	2.22	0.81
hepatoma cell line:Li-7	10484-107A7	30.81	26.47	0.89	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	43.42	29.65	0.70	1.81
hippocampus - adult, donor10196	10169-103B7	15.14	21.77	0.00	1.89
hippocampus, adult, donor10252	10153-102I9	12.04	21.84	0.61	6.33
hippocampus, adult, donor10258	10374-105G5	1.99	6.97	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	9.87	22.56	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	53.71	63.48	4.27	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	41.82	45.16	2.55	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	36.81	49.00	1.78	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	27.63	43.42	3.95	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	25.82	60.94	8.52	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	27.71	59.60	4.56	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.06	43.50	2.04	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	23.27	41.58	3.23	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	29.20	44.21	0.00	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	27.70	42.15	0.95	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	31.18	46.13	3.86	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	34.34	40.40	0.00	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	43.82	39.28	3.29	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	44.22	35.37	5.90	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	26.18	36.66	6.11	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	20.81	56.32	2.29	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	20.93	49.28	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	15.99	59.47	0.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.03	19.40	0.75	3.20
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.91	17.73	0.91	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.14	16.91	0.63	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.27	34.62	1.31	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.87	26.42	2.32	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	14.35	37.66	0.60	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	57.09	48.59	4.43	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	51.64	40.51	2.57	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	55.53	47.77	5.31	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	25.35	47.53	5.99	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	28.51	34.84	2.53	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	24.51	57.80	3.63	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.10	22.75	1.03	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	19.92	33.21	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.01	30.01	0.77	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.29	41.16	2.81	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	13.63	30.29	4.54	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	20.50	41.00	3.36	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	52.89	40.09	3.62	2.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	29.41	47.24	4.01	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	60.49	50.24	1.46	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	37.90	52.87	3.06	2.75
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	152.90	26.03	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	29.78	71.48	4.63	4.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	22.44	20.80	0.55	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	18.46	29.31	0.36	3.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	17.08	28.83	0.71	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	33.41	5.97	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	31.96	45.91	1.49	3.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	13.74	34.48	0.54	3.23
immature langerhans cells, donor1	11904-125F5	3.63	14.29	0.00	0.00
immature langerhans cells, donor2	11905-125F6	8.71	11.88	0.00	0.00
insula, adult, pool1	10039-101F3	10.88	31.04	0.57	3.31
keratoacanthoma cell line:HKA-1	10791-110H8	23.09	15.93	0.00	0.65
kidney, adult, pool1	10017-101C8	32.64	25.53	0.70	0.60
kidney, fetal, pool1	10045-101F9	18.60	27.87	0.07	1.98
large cell lung carcinoma cell line:IA-LM	10509-107D5	27.55	47.86	0.57	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.32	17.42	1.24	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.58	13.95	0.18	0.55
left atrium, adult, donor1	10079-102A7	18.52	8.72	0.00	0.00
left ventricle, adult, donor1	10078-102A6	5.06	8.09	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	17.24	21.07	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	41.31	15.45	3.95	0.36
leiomyoma cell line:15242A	10570-108B3	48.91	20.11	5.43	1.09
leiomyoma cell line:15425	10571-108B4	48.81	23.31	5.10	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	24.05	36.59	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	35.30	43.09	0.59	0.12
liposarcoma cell line:KMLS-1	10782-110G8	47.02	24.21	0.47	1.09
liposarcoma cell line:SW 872	10726-110A6	42.40	35.33	0.49	0.37
liver, adult, pool1	10018-101C9	13.94	12.32	0.00	0.00
liver, fetal, pool1	10086-102B5	35.75	18.81	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	43.75	30.48	0.15	4.37
locus coeruleus, adult, donor10252	10165-103B3	35.80	29.34	0.55	8.12
locus coeruleus, adult, donor10258	10375-105G6	37.52	24.55	3.39	4.23
locus coeruleus, newborn, donor10223	10362-105F2	19.77	10.09	0.42	2.94
lung adenocarcinoma cell line:A549	10499-107C4	69.20	12.87	0.42	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	6.89	15.86	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	4.88	36.12	0.26	0.13
lung, adult, pool1	10019-101D1	14.77	21.38	0.24	0.47
lung, fetal, donor1	10068-101I5	6.28	17.12	0.57	2.57
lung, right lower lobe, adult, donor1	10075-102A3	5.96	23.37	0.92	0.92
lymph node, adult, donor1	10077-102A5	10.41	21.30	1.89	0.95
lymphangiectasia cell line:DS-1	10727-110A7	12.27	30.25	0.00	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	19.77	33.81	1.21	3.02
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	13.59	10.19	0.00	0.85
mature adipocyte, donor1	12231-129F8	31.08	15.98	0.00	0.00
mature adipocyte, donor2	12232-129F9	29.88	13.28	0.00	0.42
mature adipocyte, donor3	12233-129G1	30.34	12.09	0.00	0.24
mature adipocyte, donor4	12234-129G2	226.10	10.27	2.11	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	2.62	15.49	0.00	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	6.77	23.69	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	9.93	23.54	1.10	5.15
medial frontal gyrus, adult, donor10258	10368-105F8	7.31	17.16	0.95	2.86
medial frontal gyrus, newborn, donor10223	10352-105E1	4.26	27.30	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	4.05	22.78	1.52	2.70
medial temporal gyrus, adult, donor10252	10156-103A3	8.28	21.43	0.21	8.28
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	17.34	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	43.06	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	19.74	20.82	0.72	1.79
medulla oblongata - adult, donor10196	10174-103C3	20.12	18.17	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	26.16	32.04	0.93	6.81
medulla oblongata, adult, pool1	10038-101F2	33.47	31.10	0.24	3.75
medulla oblongata, newborn, donor10223	10361-105F1	17.36	15.97	0.35	1.39
medulloblastoma cell line:D283 Med	10838-111E1	73.51	117.79	4.21	0.66
medulloblastoma cell line:ONS-76	10759-110E3	26.29	33.75	0.00	0.49
melanoma cell line:COLO 679	10514-107E1	17.68	25.73	1.01	0.57
melanoma cell line:G-361	10465-106H6	15.74	30.13	0.27	1.09
meningioma cell line:HKBMM	10691-109F7	11.58	25.33	1.81	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	96.05	146.27	11.46	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	58.07	136.35	4.15	8.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	97.58	27.16	2.30	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	63.99	14.91	1.09	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	31.06	12.01	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	40.46	13.20	0.70	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	32.74	13.29	0.39	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.19	9.72	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	24.20	9.78	0.69	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	39.57	17.83	0.81	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	82.10	22.55	1.46	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	45.10	21.20	0.95	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	60.89	25.18	0.85	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	28.65	20.75	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	61.58	22.83	0.83	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	49.57	25.13	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	39.81	16.95	1.43	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.27	16.18	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	46.55	19.97	0.93	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	64.98	8.66	2.51	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	82.65	17.62	3.78	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	39.15	22.27	1.49	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	81.32	16.46	1.58	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	42.71	15.83	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	46.64	16.60	2.58	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.05	37.05	7.16	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	52.52	18.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	43.99	18.42	1.53	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	58.63	21.73	1.57	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	42.82	16.94	1.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.48	19.77	2.12	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	50.09	19.97	1.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	46.37	16.90	1.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	46.80	17.15	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	63.16	21.34	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	54.88	18.07	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	56.72	19.47	2.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	52.80	10.27	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	48.00	16.45	2.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	53.22	14.33	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	48.97	22.77	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	21.88	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	42.55	20.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	53.83	21.82	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	40.51	22.92	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	24.53	23.72	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	36.54	24.49	1.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	12.59	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	35.76	18.88	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	31.43	11.27	3.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	31.68	24.37	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	32.94	25.97	1.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.38	17.94	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	12.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	7.98	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	6.89	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	32.19	13.85	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	30.19	19.86	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	21.22	13.56	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	32.11	19.64	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	34.75	9.36	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	59.13	22.47	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	74.47	10.27	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	72.28	11.70	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	959.43	12.37	27.71	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	814.21	5.61	19.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	907.03	12.72	26.71	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1676.41	7.66	41.91	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2003.96	6.54	47.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1848.64	8.87	50.68	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	241.54	2.43	3.03	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	280.18	0.00	13.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	252.87	3.29	9.88	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	371.65	11.31	4.37	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	514.32	12.98	8.76	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	485.89	14.26	16.30	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	6.19	12.38	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	16.06	23.15	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	44.48	22.47	0.23	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	12.82	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	18.80	13.46	0.10	0.72
mesothelioma cell line:Mero-25	10850-111F4	13.39	12.03	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	22.00	31.05	1.22	0.73
mesothelioma cell line:Mero-48a	10852-111F6	28.79	28.12	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	21.02	15.77	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	50.39	22.13	1.36	0.85
mesothelioma cell line:Mero-84	10855-111F9	23.51	18.20	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	12.84	18.84	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	27.83	23.69	0.99	0.00
mesothelioma cell line:NCI-H226	10846-111E9	30.41	12.85	0.90	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	23.74	20.33	1.54	0.68
mesothelioma cell line:NCI-H28	10845-111E8	25.19	19.08	2.04	1.02
mesothelioma cell line:No36	10857-111G2	78.61	41.75	1.63	2.28
mesothelioma cell line:ONE58	10858-111G3	23.30	16.80	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	8.64	37.62	0.96	2.11
migratory langerhans cells, donor2	11902-125F3	4.52	26.13	0.49	0.85
migratory langerhans cells, donor3	11903-125F4	3.41	20.82	0.36	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.00	21.22	2.94	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	9.33	44.29	1.91	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	15.20	20.04	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.51	29.88	0.38	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	44.90	48.42	1.29	1.29
myeloma cell line:PCM6	10474-106I6	20.36	22.14	0.20	3.16
myxofibrosarcoma cell line:MFH-ino	10600-108E6	44.13	27.90	0.00	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	24.52	16.28	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.27	10.36	0.33	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	14.19	10.15	0.15	0.59
nasal epithelial cells, donor2	12227-129F4	12.70	8.83	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	88.57	148.62	1.15	2.30
neuroblastoma cell line:NB-1	10539-107G8	48.08	96.16	0.56	2.43
neuroblastoma cell line:NBsusSR	10607-108F4	26.57	36.27	2.53	0.63
neuroblastoma cell line:NH-12	10555-107I6	31.49	87.40	1.49	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	17.08	30.84	2.14	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	25.97	28.67	1.11	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	77.89	36.83	0.40	3.02
neuroepithelioma cell line:SK-N-MC	10728-110A8	35.60	40.05	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	54.03	29.28	0.80	0.27
neutrophil PMN, donor1	12133-128D9	0.00	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	28.41	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	11.50	77.80	0.85	3.21
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	13.61	91.26	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	20.52	31.42	0.00	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.61	18.39	2.36	1.05
nucleus accumbens, adult, pool1	10037-101F1	15.19	24.65	0.28	2.81
occipital cortex - adult, donor10196	10172-103C1	10.30	10.30	2.06	4.12
occipital cortex, adult, donor10252	10163-103B1	10.47	25.23	0.00	9.12
occipital cortex, newborn, donor10223	10355-105E4	12.74	23.66	0.00	1.09
occipital lobe, adult, donor1	10076-102A4	9.18	27.81	0.26	2.36
occipital lobe, fetal, donor1	10073-102A1	35.62	62.65	1.29	0.43
occipital pole, adult, pool1	10036-101E9	9.15	27.75	0.16	1.89
olfactory region, adult	10195-103E6	7.26	18.15	0.57	2.87
optic nerve, donor1	10277-104E7	10.01	30.02	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	45.22	9.11	0.11	1.37
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	19.78	36.27	0.82	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	26.25	17.95	3.56	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	14.79	20.45	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	29.10	24.99	1.18	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.02	23.36	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	103.48	23.11	1.06	2.54
ovary, adult, pool1	10020-101D2	9.08	18.43	0.00	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	49.31	35.56	0.37	0.73
pancreas, adult, donor1	10049-101G4	20.69	21.63	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.90	27.67	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	21.81	26.40	2.90	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	15.90	28.15	0.50	0.83
paracentral gyrus, adult, pool1	10035-101E8	13.82	26.91	0.09	2.01
parietal cortex, adult, donor10258	10373-105G4	13.21	11.01	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	7.52	15.99	0.00	2.82
parietal lobe, adult, donor10252	10157-103A4	8.84	24.23	0.57	5.13
parietal lobe, adult, pool1	10034-101E7	13.31	29.34	0.09	3.70
parietal lobe, fetal, donor1	10072-101I9	14.55	65.95	2.91	0.97
parietal lobe, newborn, donor10223	10356-105E5	12.34	17.20	0.37	0.75
parotid gland, adult	10199-103F1	19.12	16.03	1.85	0.00
penis, adult	10200-103F2	26.32	18.26	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	14.69	10.04	0.74	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	6.26	11.07	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	190.28	104.49	0.65	5.81
pineal gland, adult, donor10252	10160-103A7	172.93	95.94	1.78	20.14
pineal gland, adult, donor10258	10377-105G8	126.67	54.56	1.88	2.51
pituitary gland - adult, donor10196	10180-103C9	7.08	23.27	0.00	11.13
pituitary gland, adult, donor10252	10162-103A9	6.78	22.41	0.52	30.75
pituitary gland, adult, donor10258	10378-105G9	6.81	17.02	0.85	5.96
placenta, adult, pool1	10021-101D3	10.21	25.69	0.43	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	11.65	26.35	1.72	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	7.94	14.16	0.16	0.00
pons, adult, pool1	10033-101E6	37.96	40.88	0.26	3.01
postcentral gyrus, adult, pool1	10032-101E5	8.98	30.51	0.35	2.88
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	31.37	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	46.94	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	46.76	55.50	1.89	3.64
prostate cancer cell line:PC-3	10439-106E7	28.13	31.22	0.18	0.73
prostate, adult, pool1	10022-101D4	13.60	19.86	0.27	1.00
putamen, adult, donor10196	10176-103C5	16.76	18.41	0.71	4.25
putamen, adult, donor10252	10152-102I8	17.65	15.69	1.96	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	4.37	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	21.50	14.98	0.72	2.66
putamen, newborn, donor10223	10365-105F5	19.49	11.24	2.25	4.50
rectal cancer cell line:TT1TKB	10469-106I1	24.44	14.26	0.00	0.29
rectum, fetal, donor1	10067-101I4	23.65	54.25	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.82	27.14	2.54	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	28.17	21.12	1.24	1.24
retina, adult, pool1	10030-101E3	7.36	20.48	0.30	2.68
retinoblastoma cell line:Y79	10475-106I7	130.68	97.69	3.12	5.20
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.18	24.59	0.12	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.59	34.31	0.56	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.09	25.01	0.76	0.00
salivary acinar cells, donor1	11771-123I7	14.41	11.65	0.32	0.16
salivary acinar cells, donor2	11772-123I8	7.99	13.49	0.41	0.28
salivary acinar cells, donor3	11773-123I9	5.30	16.55	0.00	0.00
salivary gland, adult, pool1	10093-102C3	10.87	16.01	0.57	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.34	24.45	0.76	1.01
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	30.68	27.62	0.35	1.41
seminal vesicle, adult	10201-103F3	2.65	19.05	0.53	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	8.50	17.49	1.21	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.60	19.63	1.76	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	38.13	33.12	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	23.64	37.48	0.81	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	14.92	12.27	0.11	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	62.71	43.48	0.77	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	1.42	10.64	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	4.80	8.40	0.00	0.24
skeletal muscle, fetal, donor1	10066-101I3	14.07	16.08	0.00	2.01
skin, adult, donor1	10074-102A2	40.71	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	156.54	30.93	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	57.37	30.68	0.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	24.90	59.26	2.21	6.30
small cell lung carcinoma cell line:DMS 144	10841-111E4	14.26	48.38	2.70	1.54
small cell lung carcinoma cell line:LK-2	10541-107H1	13.85	52.42	0.16	4.62
small cell lung carcinoma cell line:NCI-H82	10842-111E5	64.82	124.02	4.50	1.93
small cell lung carcinoma cell line:WA-hT	10562-108A4	8.50	22.01	0.87	1.53
small intestine, adult, pool1	10024-101D6	32.01	23.77	0.24	0.60
small intestine, fetal, donor1	10064-101I1	23.59	25.31	0.74	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	4.10	23.59	2.05	1.54
smooth muscle, adult, pool1	10048-101G3	6.98	16.80	0.26	1.03
somatostatinoma cell line:QGP-1	10781-110G7	10.45	47.71	0.00	1.88
spinal cord - adult, donor10196	10181-103D1	22.25	23.63	0.00	1.61
spinal cord, adult, donor10252	10159-103A6	16.95	22.08	0.39	6.31
spinal cord, adult, donor10258	10369-105F9	25.60	8.99	0.69	6.23
spinal cord, fetal, donor1	10056-101H2	60.37	54.89	3.05	2.44
spinal cord, newborn, donor10223	10359-105E8	28.93	26.63	0.92	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	65.12	31.66	0.60	0.00
spleen, adult, pool1	10025-101D7	9.25	25.44	0.33	1.21
spleen, fetal, pool1	10044-101F8	11.28	28.84	0.08	1.27
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	19.98	30.02	0.52	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	4.75	16.33	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	13.63	22.36	3.84	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	12.12	16.42	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	14.41	26.00	0.45	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	19.91	24.99	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	22.42	26.65	0.00	0.00
stomach, fetal, donor1	10062-101H8	7.48	19.22	0.00	0.00
submaxillary gland, adult	10202-103F4	11.96	17.66	1.14	2.85
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	9.35	24.72	0.21	7.69
substantia nigra, adult, donor10258	10371-105G2	38.79	16.03	0.52	5.69
substantia nigra, newborn, donor10223	10358-105E7	15.54	19.78	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	49.98	57.77	0.92	0.92
temporal lobe, adult, pool1	10031-101E4	9.32	30.77	0.42	2.29
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	19.94	79.77	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	16.26	54.94	0.88	0.44
tenocyte, donor1	11763-123H8	50.27	24.44	3.14	0.00
tenocyte, donor2	11765-123I1	13.35	11.06	0.76	0.76
tenocyte, donor3	11768-123I4	25.21	15.57	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	61.87	74.27	2.21	3.74
teratocarcinoma cell line:NCR-G1	10798-110I6	34.22	30.21	0.46	2.16
teratocarcinoma cell line:PA-1	10807-111A6	38.74	39.83	0.77	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	36.56	40.37	1.14	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	3.03	27.98	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	5.34	14.94	0.33	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	29.31	35.18	4.89	0.33
testis, adult, pool1	10026-101D8	14.50	26.63	0.43	4.40
testis, adult, pool2	10096-102C6	18.95	27.97	1.35	4.96
thalamus - adult, donor10196	10168-103B6	16.56	19.87	1.10	6.62
thalamus, adult, donor10252	10154-103A1	13.60	22.04	0.47	7.81
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	13.86	0.00	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.55	23.55	0.33	2.64
thalamus, newborn, donor10223	10366-105F6	18.41	20.14	0.58	3.45
throat, adult	10209-103G2	8.99	14.23	0.00	1.00
throat, fetal, donor1	10061-101H7	9.75	20.72	0.30	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	32.00	41.93	1.39	1.79
thymus, adult, pool1	10027-101D9	7.26	43.34	0.50	1.79
thymus, fetal, pool1	10043-101F7	11.64	28.99	0.31	5.61
thyroid carcinoma cell line:KHM-5M	10776-110G2	20.08	35.90	0.53	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	23.19	17.04	0.42	0.42
thyroid, adult, pool1	10028-101E1	7.28	23.70	0.56	1.59
thyroid, fetal, donor1	10060-101H6	10.28	23.73	1.05	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	0.00	9.24	0.00	0.00
tongue, adult	10203-103F5	11.63	12.09	0.93	0.70
tongue, fetal, donor1	10059-101H5	9.46	15.76	1.58	0.79
tonsil, adult, pool1	10047-101G2	13.92	30.55	0.00	1.20
trachea, adult, pool1	10029-101E2	14.31	22.00	0.25	0.08
trachea, fetal, donor1	10058-101H4	22.70	31.93	0.77	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	40.74	24.80	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	24.82	43.36	0.41	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	28.83	37.45	0.63	0.47
tridermal teratoma cell line:HGRT	10694-109G1	11.42	47.56	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	12.02	22.77	0.25	0.17
umbilical cord, fetal, donor1	10057-101H3	22.95	22.95	0.00	2.09
uterus, adult, pool1	10100-102D1	7.00	16.89	0.34	1.19
uterus, fetal, donor1	10055-101H1	17.41	31.23	0.00	0.00
vagina, adult	10204-103F6	10.34	11.63	0.00	1.94
vein, adult	10191-103E2	11.40	21.04	1.53	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	18.16	27.50	0.80	0.80